title: Gene expression profiles of hepatoma cell line HLE.
abstract: OBJECTIVE
  To investigate the global gene expression of cancer related genes in hepatoma cell line HLE using Atlas Human Cancer Array membranes with 588 well-characterized human genes related with cancer and tumor biology.
  
  
  METHODS
  Hybridization of cDNA blotting membrane was performed with (32)P-labeled cDNA probes synthesized from RNA isolated from Human hepatoma cell line HLE and non-cirrhotic normal liver which was liver transplantation donor. AtlasImage, a software specific to array, was used to analyze the result. The expression pattern of some genes identified by Atlas arrays hybridization was confirmed by reverse transcription polymerase chain reaction (RT-PCR) in 24 pairs of specimens and Northern blot of 4 pairs of specimens.
  
  
  RESULTS
  The differential expression of cell cycle/growth regulator in hepatocellular carcinoma (HCC) showed a stronger tendency toward cell proliferation with more than 1.5-fold up-regulation of Cyclin C, ERK5, ERK6, E2F-3, TFDP-2 and CK4. The anti-apoptotic factors such as Akt-1 were up-regulated, whereas the promotive genes of apoptosis such as ABL2 were down-regulated. Among oncogene/tumors suppressors, SKY was down-regulated. Some genes such as Integrin beta 8, Integrin beta 7, DNA-PK, CSPCP, byglycan, Tenacin and DNA Topo were up-regulated. A number of genes, including LAR, MEK1, eps15, TDGF1, ARHGDIA were down-regulated. In general, expression of the cancer progression genes was up-regulated, while expression of anti-cancer progression genes was down-regulated. These differentially expressed genes tested with RT-PCR were in consistent with cDNA array findings.
  
  
  CONCLUSIONS
  Investigation of these genes in HCC is helpful in disclosing molecular mechanism of pathogenesis and progression of HCC. For the first time few genes were discovered in HCC. Further study is required for the precise relationship between the altered genes and their correlation with the pathogenesis of HCC.
authors.affiliation: Department of Surgery, the First Clinical College of Harbin Medical University, No.23 Youzheng Street, Nangang District, Harbin 150001, China. liulianxin@sohu.com
authors.forename: Lian-Xin
authors.initials: LX
authors.lastname: Liu
authors.forename: Zhi-Hua
authors.initials: ZH
authors.lastname: Liu
authors.forename: Hong-Chi
authors.initials: HC
authors.lastname: Jiang
authors.forename: Wei-Hui
authors.initials: WH
authors.lastname: Zhang
authors.forename: Shu-Yi
authors.initials: SY
authors.lastname: Qi
authors.forename: Jie
authors.initials: J
authors.lastname: Hu
authors.forename: Xiu-Qin
authors.initials: XQ
authors.lastname: Wang
authors.forename: Min
authors.initials: M
authors.lastname: Wu
mesh_terms: D001483:Base Sequence; D006528:Carcinoma, Hepatocellular / Q000235:genetics*; D002453:Cell Cycle / Q000235:genetics; D002455:Cell Division / Q000235:genetics; D016213:Cyclins / Q000235:genetics; D017931:DNA Primers; D018076:DNA, Complementary / Q000235:genetics; D020869:Gene Expression Profiling; D006801:Humans; D008113:Liver Neoplasms / Q000235:genetics*; D020928:Mitogen-Activated Protein Kinases / Q000235:genetics; D012334:RNA, Neoplasm / Q000235:genetics / Q000302:isolation & purification; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014407:Tumor Cells, Cultured
chemical_list: D016213:Cyclins; D017931:DNA Primers; D018076:DNA, Complementary; D012334:RNA, Neoplasm; D020928:Mitogen-Activated Protein Kinases